Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 377
Filter
1.
Urology ; 158: 102-109, 2021 12.
Article in English | MEDLINE | ID: mdl-34536411

ABSTRACT

OBJECTIVE: To clarify the effects of cellular self-aggregation of adipose-derived stem cells (ADSCs) on erectile function (EF). METHODS: A model of neurogenic erectile dysfunction was performed using bilateral cavernous nerve crush injury in rats. ADSCs suspensions (1 × 106/0.2 ml), were administered via intracavernous injection (ICI) after being allowed to shelve for 0 minute (ICI 0) or 60 minutes (ICI 60) in vitro, as well as cell aggregates isolated from ICI 60 (ICI A). The caudal vein injection group (CVI 60) was used to evaluate whether cell self-aggregation was beneficial to EF when introduced into the peripheral circulation. One day after the transplantation, the distribution of cells was observed. EF and histopathological changes were evaluated after 4 weeks. RESULTS: Approximately 85% of ADSCs self-aggregated into cell clusters at 60 minutes. The ICI 60 had more significant improvements in EF and more visualized ADSCs retained in the corpus cavernosum (CC) than ICI 0 and CVI 60 (P <.05), but no significant difference between ICI 60 and ICI A. In the CVI 60 group, the cell clusters formed by self-aggregation could hardly reach the CC and were mostly found in lung tissue. Immunofluorescence staining showed increased the content of expressing biomarkers of smooth muscle, nerve within the CC tissue in the ICI groups when compared to the CVI group. CONCLUSION: ADSCs self-aggregation before ICI may be an influential factor in the treatment of neurogenic erectile dysfunction. Its potential mechanism may be through improving cell retention in the CC.


Subject(s)
Cell Aggregation , Erectile Dysfunction/therapy , Mesenchymal Stem Cell Transplantation/methods , Mesenchymal Stem Cells/physiology , Adipose Tissue/cytology , Animals , Disease Models, Animal , Erectile Dysfunction/etiology , Erectile Dysfunction/physiopathology , Injections, Intravenous , Male , Muscle, Smooth/pathology , Nitric Oxide Synthase Type I/metabolism , Penile Erection , Penis/innervation , Penis/pathology , Peripheral Nerve Injuries/complications , Peripheral Nerves/enzymology , Rats
2.
Mol Cell Proteomics ; 19(9): 1418-1435, 2020 09.
Article in English | MEDLINE | ID: mdl-32518069

ABSTRACT

Synaptic transmission leading to release of neurotransmitters in the nervous system is a fast and highly dynamic process. Previously, protein interaction and phosphorylation have been thought to be the main regulators of synaptic transmission. Here we show that sialylation of N-linked glycosylation is a novel potential modulator of neurotransmitter release mechanisms by investigating depolarization-dependent changes of formerly sialylated N-linked glycopeptides. We suggest that negatively charged sialic acids can be modulated, similarly to phosphorylation, by the action of sialyltransferases and sialidases thereby changing local structure and function of membrane glycoproteins. We characterized site-specific alteration in sialylation on N-linked glycoproteins in isolated rat nerve terminals after brief depolarization using quantitative sialiomics. We identified 1965 formerly sialylated N-linked glycosites in synaptic proteins and found that the abundances of 430 glycosites changed after 5 s depolarization. We observed changes on essential synaptic proteins such as synaptic vesicle proteins, ion channels and transporters, neurotransmitter receptors and cell adhesion molecules. This study is to our knowledge the first to describe ultra-fast site-specific modulation of the sialiome after brief stimulation of a biological system.


Subject(s)
Membrane Glycoproteins/metabolism , Neurotransmitter Agents/metabolism , Peripheral Nerves/metabolism , Proteome/metabolism , Sialic Acids/metabolism , Synapses/metabolism , Synaptic Membranes/metabolism , Animals , Chlorates/pharmacology , Chromatography, Liquid , Glycosides/metabolism , Glycosylation , Male , Membrane Glycoproteins/chemistry , Peripheral Nerves/enzymology , Peripheral Nerves/physiology , Proteome/chemistry , Proteome/drug effects , Proteome/physiology , Proteomics , Rats , Rats, Sprague-Dawley , Receptors, N-Methyl-D-Aspartate/chemistry , Sialic Acids/chemistry , Signal Transduction/drug effects , Signal Transduction/physiology , Synapses/chemistry , Synapses/drug effects , Synapses/physiology , Synaptic Membranes/drug effects , Synaptic Membranes/enzymology , Tandem Mass Spectrometry
3.
Mod Pathol ; 33(3): 420-430, 2020 03.
Article in English | MEDLINE | ID: mdl-31481664

ABSTRACT

Lipomatosis of nerve is a rare malformation characterized by a fibrolipomatous proliferation within peripheral nerve. Lipomatosis of nerve most frequently involves the median nerve, and manifests clinically as a compressive neuropathy. However, 30-60% of cases are associated with tissue overgrowth within the affected nerve's territory (e.g., macrodactyly for lipomatosis of nerve in the distal median nerve). Somatic activating PIK3CA mutations have been identified in peripheral nerve from patients with lipomatosis of nerve with type I macrodactyly, which is now classified as a PIK3CA-related overgrowth spectrum disorder. However, the PIK3CA mutation status of histologically confirmed lipomatosis of nerve, including cases involving proximal nerves, and cases without territory overgrowth, has not been determined. Fourteen histologically confirmed cases of lipomatosis of nerve involving the median (N = 6), brachial plexus (N = 1), ulnar (N = 3), plantar (N = 2), sciatic and superficial peroneal nerves (N = 1 each) were included. Ten cases had nerve territory overgrowth, ranging from macrodactyly to hemihypertrophy; and four cases had no territory overgrowth. Exome sequencing revealed "hotspot" activating PIK3CA missense mutations in 6/7 cases. Droplet digital polymerase chain reaction for the five most common PIK3CA mutations (p.H1047R, p.H1047L, p.E545K, p.E542K, and p.C420R) confirmed the exome results and identified an additional six cases with mutations (12/14 total). PIK3CA mutations were found in 8/10 cases with territory overgrowth (N = 7 p.H1047R and N = 1 p.E545K), including two proximal nerve cases with extremity overgrowth, and 4/4 cases without territory overgrowth (p.H1047R and p.H1047L, N = 2 each). The variant allele frequency of PIK3CA mutations (6-32%) did not correlate with the overgrowth phenotype. Three intraneural lipomas had no detected PIK3CA mutations. As PIK3CA mutations are frequent events in lipomatosis of nerve, irrespective of anatomic site or territory overgrowth, we propose that all phenotypic variants of this entity be classified within the PIK3CA-related overgrowth spectrum and termed "PIK3CA-related lipomatosis of nerve".


Subject(s)
Cell Proliferation , Class I Phosphatidylinositol 3-Kinases/genetics , Lipomatosis/genetics , Mutation , Peripheral Nerves/enzymology , Peripheral Nervous System Diseases/genetics , Adult , Child , Child, Preschool , DNA Mutational Analysis , Female , Genetic Predisposition to Disease , Humans , Infant, Newborn , Lipomatosis/enzymology , Lipomatosis/pathology , Male , Peripheral Nerves/pathology , Peripheral Nervous System Diseases/enzymology , Peripheral Nervous System Diseases/pathology , Phenotype , Polymerase Chain Reaction , Terminology as Topic , Exome Sequencing
4.
EMBO J ; 37(23)2018 12 03.
Article in English | MEDLINE | ID: mdl-30420557

ABSTRACT

A set of glutamylases and deglutamylases controls levels of tubulin polyglutamylation, a prominent post-translational modification of neuronal microtubules. Defective tubulin polyglutamylation was first linked to neurodegeneration in the Purkinje cell degeneration (pcd) mouse, which lacks deglutamylase CCP1, displays massive cerebellar atrophy, and accumulates abnormally glutamylated tubulin in degenerating neurons. We found biallelic rare and damaging variants in the gene encoding CCP1 in 13 individuals with infantile-onset neurodegeneration and confirmed the absence of functional CCP1 along with dysregulated tubulin polyglutamylation. The human disease mainly affected the cerebellum, spinal motor neurons, and peripheral nerves. We also demonstrate previously unrecognized peripheral nerve and spinal motor neuron degeneration in pcd mice, which thus recapitulated key features of the human disease. Our findings link human neurodegeneration to tubulin polyglutamylation, entailing this post-translational modification as a potential target for drug development for neurodegenerative disorders.


Subject(s)
Carboxypeptidases/deficiency , Cerebellum/enzymology , Motor Neurons/enzymology , Peripheral Nerves/enzymology , Purkinje Cells/enzymology , Spine/enzymology , Spinocerebellar Degenerations/enzymology , Cerebellum/pathology , Female , GTP-Binding Proteins , Humans , Male , Motor Neurons/pathology , Peptides/genetics , Peptides/metabolism , Peripheral Nerves/pathology , Protein Processing, Post-Translational , Purkinje Cells/pathology , Serine-Type D-Ala-D-Ala Carboxypeptidase , Spine/pathology , Spinocerebellar Degenerations/genetics , Spinocerebellar Degenerations/pathology
5.
Am J Physiol Cell Physiol ; 313(3): C274-C284, 2017 Sep 01.
Article in English | MEDLINE | ID: mdl-28637679

ABSTRACT

The carotid body (CB) chemoreflex maintains blood Po2 and Pco2/H+ homeostasis and displays sensory plasticity during exposure to chronic hypoxia. Purinergic signaling via P1 and P2 receptors plays a pivotal role in shaping the afferent discharge at the sensory synapse containing catecholaminergic chemoreceptor (type I) cells, glial-like type II cells, and sensory (petrosal) nerve endings. However, little is known about the family of ectonucleotidases that control synaptic nucleotide levels. Using quantitative PCR (qPCR), we first compared expression levels of ectonucleoside triphosphate diphosphohydrolases (NTPDases1,2,3,5,6) and ecto-5'-nucleotidase (E5'Nt/CD73) mRNAs in juvenile rat CB vs. brain, petrosal ganglia, sympathetic (superior cervical) ganglia, and a sympathoadrenal chromaffin (MAH) cell line. In whole CB extracts, qPCR revealed a high relative expression of surface-located members NTPDase1,2 and E5'Nt/CD73, compared with low NTPDase3 expression. Immunofluorescence staining of CB sections or dissociated CB cultures localized NTPDase2,3 and E5'Nt/CD73 protein to the periphery of type I clusters, and in association with sensory nerve fibers and/or isolated type II cells. Interestingly, in CBs obtained from rats reared under chronic hypobaric hypoxia (~60 kPa, equivalent to 4,300 m) for 5-7 days, in addition to the expected upregulation of tyrosine hydroxylase and VEGF mRNAs, there was a significant upregulation of NTPDase3 and E5'Nt/CD73 mRNA, but a downregulation of NTPDase1 and NTPDase2 relative to normoxic controls. We conclude that NTPDase1,2,3 and E5'Nt/CD73 are the predominant surface-located ectonucleotidases in the rat CB and suggest that their differential regulation during chronic hypoxia may contribute to CB plasticity via control of synaptic ATP, ADP, and adenosine pools.


Subject(s)
5'-Nucleotidase/metabolism , Brain/enzymology , Carotid Body/enzymology , Gene Expression Regulation, Enzymologic , Hypoxia/metabolism , Neuronal Plasticity , Peripheral Nerves/enzymology , Animals , Chronic Disease , Female , Male , Rats , Rats, Wistar
6.
Glia ; 65(9): 1452-1470, 2017 09.
Article in English | MEDLINE | ID: mdl-28617998

ABSTRACT

The PI 3-kinase Vps34 (Pik3c3) synthesizes phosphatidylinositol 3-phosphate (PI3P), a lipid critical for both endosomal membrane traffic and macroautophagy. Human genetics have implicated PI3P dysregulation, and endosomal trafficking in general, as a recurring cause of demyelinating Charcot-Marie-Tooth (CMT) peripheral neuropathy. Here, we investigated the role of Vps34, and PI3P, in mouse Schwann cells by selectively deleting Vps34 in this cell type. Vps34-Schwann cell knockout (Vps34SCKO ) mice show severe hypomyelination in peripheral nerves. Vps34-/- Schwann cells interact abnormally with axons, and there is a delay in radial sorting, a process by which large axons are selected for myelination. Upon reaching the promyelinating stage, Vps34-/- Schwann cells are significantly impaired in the elaboration of myelin. Nerves from Vps34SCKO mice contain elevated levels of the LC3 and p62 proteins, indicating impaired autophagy. However, in the light of recent demonstrations that autophagy is dispensable for myelination, it is unlikely that hypomyelination in Vps34SCKO mice is caused by impaired autophagy. Endosomal trafficking is also disturbed in Vps34-/- Schwann cells. We investigated the activation of the ErbB2/3 receptor tyrosine kinases in Vps34SCKO nerves, as these proteins, which play essential roles in Schwann cell myelination, are known to traffic through endosomes. In Vps34SCKO nerves, ErbB3 was hyperphosphorylated on a tyrosine known to be phosphorylated in response to neuregulin 1 exposure. ErbB2 protein levels were also decreased during myelination. Our findings suggest that the loss of Vps34 alters the trafficking of ErbB2/3 through endosomes. Abnormal ErbB2/3 signaling to downstream targets may contribute to the hypomyelination observed in Vps34SCKO mice.


Subject(s)
Axons/enzymology , Class III Phosphatidylinositol 3-Kinases/deficiency , Neuronal Outgrowth/physiology , Receptor, ErbB-2/metabolism , Receptor, ErbB-3/metabolism , Schwann Cells/enzymology , Animals , Autophagy/physiology , Axons/pathology , Cell Proliferation/physiology , Class III Phosphatidylinositol 3-Kinases/genetics , Endosomes/enzymology , Endosomes/pathology , Female , Male , Mice, 129 Strain , Mice, Inbred C57BL , Mice, Knockout , Motor Activity/physiology , Peripheral Nerves/enzymology , Peripheral Nerves/growth & development , Peripheral Nerves/pathology , Phosphorylation , Schwann Cells/pathology , Sciatic Nerve/enzymology , Sciatic Nerve/growth & development , Sciatic Nerve/pathology , Signal Transduction
7.
J Neurochem ; 141(1): 37-47, 2017 04.
Article in English | MEDLINE | ID: mdl-27973735

ABSTRACT

Myelination in the peripheral nervous system (PNS) is controlled by both positive and negative regulators within Schwann cells to ensure timely onset and correct myelin thickness for saltatory conduction by neurons. Transcription factors such as Sox10, octamer-binding transcription factor 6 (Oct6) and Krox20 form a positive regulatory network, whereas negative regulators such as cJun and Sox2 oppose myelination in Schwann cells. The role of the p38 MAPK pathway has been studied in PNS myelination, but its precise function remains unclear, with both positive and negative effects of p38 activity reported upon both myelination and processes of nerve repair. To clarify the role of p38 MAPK in the PNS, we have analysed mice with a Schwann cell-specific ablation of the major p38 isoform, p38alpha. In line with previous findings of an inhibitory role for p38 MAPK, we observe acceleration of post-natal myelination in p38alpha null nerves, a delay in myelin down-regulation following injury, together with a small increase in levels of re-myelination following injury. Finally we explored roles for p38alpha in controlling axonal regeneration and functional repair following PNS injury and observe that loss of p38alpha function in Schwann cells does not appear to affect these processes as previously reported. These studies therefore provide further proof for a role of p38 MAPK signalling in the control of myelination by Schwann cells in the PNS, but do not show an apparent role for signalling by this MAP kinase in Schwann cells controlling other elements of Wallerian degeneration and functional repair following injury. Cover Image for this issue: doi: 10.1111/jnc.13793.


Subject(s)
Mitogen-Activated Protein Kinase 14/physiology , Nerve Fibers, Myelinated/enzymology , Peripheral Nerve Injuries/enzymology , Peripheral Nerves/enzymology , Recovery of Function/physiology , Schwann Cells/enzymology , Animals , Animals, Newborn , Cells, Cultured , Female , Male , Mice , Nerve Fibers, Myelinated/pathology , Peripheral Nerve Injuries/pathology , Peripheral Nerves/pathology , Rats , Schwann Cells/pathology
8.
eNeuro ; 4(6)2017.
Article in English | MEDLINE | ID: mdl-29379870

ABSTRACT

Vital motor functions, such as respiration and locomotion, rely on the ability of spinal motor neurons (MNs) to acquire stereotypical positions in the ventral spinal cord and to project with high precision to their peripheral targets. These key properties of MNs emerge during development through transcriptional programs that dictate their subtype identity and connectivity; however, the molecular mechanisms that establish the transcriptional landscape necessary for MN specification are not fully understood. Here, we show that the enzyme topoisomerase IIß (Top2ß) controls MN migration and connectivity. Surprisingly, Top2ß is not required for MN generation or survival but has a selective role in columnar specification. In the absence of Top2ß, phrenic MN identity is eroded, while other motor columns are partially preserved but fail to cluster to their proper position. In Top2ß-/- mice, peripheral connectivity is impaired as MNs exhibit a profound deficit in terminal branching. These defects likely result from the insufficient activation of Hox/Pbx-dependent transcriptional programs as Hox and Pbx genes are downregulated in the absence of Top2ß. Top2ß mutants recapitulate many aspects of Pbx mutant mice, such as MN disorganization and defects in medial motor column (MMC) specification. Our findings indicate that Top2ß, a gene implicated in neurodevelopmental diseases such as autism spectrum disorders, plays a critical, cell-specific role in the assembly of motor circuits.


Subject(s)
DNA Topoisomerases, Type II/deficiency , Homeodomain Proteins/metabolism , Motor Neurons/enzymology , Motor Neurons/pathology , Poly-ADP-Ribose Binding Proteins/deficiency , Animals , Cell Movement/physiology , Cell Survival/physiology , DNA Topoisomerases, Type II/genetics , Female , Green Fluorescent Proteins/genetics , Green Fluorescent Proteins/metabolism , Male , Mice, Transgenic , Neural Pathways/enzymology , Neural Pathways/pathology , Neural Stem Cells/enzymology , Neural Stem Cells/pathology , Neurogenesis/physiology , Peripheral Nerves/enzymology , Peripheral Nerves/growth & development , Peripheral Nerves/pathology , Poly-ADP-Ribose Binding Proteins/genetics , Spinal Cord/enzymology , Spinal Cord/growth & development , Spinal Cord/pathology
9.
Neuroscience ; 320: 93-104, 2016 Apr 21.
Article in English | MEDLINE | ID: mdl-26851772

ABSTRACT

Although thrombin has an important role in both central and peripheral nerve diseases, characterization of the anatomical distribution of its proteolytic activity has been limited by available methods. This study presents the development, challenges, validation and implementation of a novel histochemical method for visualization of thrombin activity in the nervous system. The method is based on the cleavage of the substrate, Boc-Asp(OBzl)-Pro-Arg-4MßNA by thrombin to liberate free 4-methoxy-2-naphthylamine (4MßNA). In the presence of 5-nitrosalicylaldehyde, free 4MßNA is captured, yielding an insoluble yellow fluorescent precipitate which marks the site of thrombin activity. The sensitivity of the method was determined in vitro using known concentrations of thrombin while the specificity was verified using a highly specific thrombin inhibitor. Using this method we determined the spatial distribution of thrombin activity in mouse brain following transient middle cerebral artery occlusion (tMCAo) and in mouse sciatic nerve following crush injury. Fluorescence microscopy revealed well-defined thrombin activity localized to the right ischemic hemisphere in cortical areas and in the striatum compared to negligible thrombin activity contralaterally. The histochemical localization of thrombin activity following tMCAo was in good correlation with the infarct areas per triphenyltetrazolium chloride staining and to thrombin activity measured biochemically in tissue punches (85 ± 35 and 20 ± 3 mU/ml, in the cortical and striatum areas respectively, compared to 7 ± 2 and 13 ± 2 mU/ml, in the corresponding contralateral areas; mean ± SEM; p<0.05). In addition, 24 h following crush injury, focal areas of highly elevated thrombin activity were detected in teased sciatic fibers. This observation was supported by the biochemical assay and western blot technique. The histochemical method developed in this study can serve as an important tool for studying the role of thrombin in physiological and pathological conditions.


Subject(s)
Brain/enzymology , Histocytochemistry/methods , Peripheral Nerves/enzymology , Thrombin/analysis , Animals , Disease Models, Animal , Mice , Peripheral Nerve Injuries/enzymology , Sensitivity and Specificity , Stroke/enzymology
10.
Int Urol Nephrol ; 48(5): 657-69, 2016 May.
Article in English | MEDLINE | ID: mdl-26820518

ABSTRACT

PURPOSE: Erectile dysfunction (ED) is a distressing complication in men with diabetes mellitus (DM). This study aimed to investigate the effects of adipose-derived stem cells (ADSCs) plus insulin on ED in streptozotocin (STZ)-induced diabetic rats. METHODS: Forty-five eight-week-old male Sprague-Dawley rats received intraperitoneal injection of STZ (60 mg/kg). Eight weeks after the induction, the determined diabetic rats were randomly distributed into four groups: rats in DM + PBS group received a one-time intracavernous (IC) injection of phosphate-buffered saline (PBS) solution, DM + ADSCs group received IC injection of ADSCs, DM + Insulin group received subcutaneous injection of neutral protamine Hagedorn twice a day, and DM + ADSCs + Insulin group received both ADSCs and neutral protamine Hagedorn treatments. Another 10 normal rats were served as control group and received IC injection of PBS. Four weeks after the treatments, intracavernous pressure, histopathological changes in penis, functional proteins of ADSCs, and penis were measured. RESULTS: We found that ADSCs expressed vascular endothelial growth factor, TIMP metallopeptidase inhibitor 1 (TIMP-1), and lipopolysaccharide-inducible CXC chemokine (LIX). ADSC injection partially restored cavernous endothelium and smooth muscle contents and nNOS-positive nerves, and reduced apoptosis in penis compared with PBS-treated diabetic rats. Insulin treatment could further modulate inflammatory response and reduce advanced glycation end-product accumulation in penis. CONCLUSIONS: Better than single therapy, ADSCs combined with insulin ameliorate ED and pathological changes in diabetic rats to near-normal levels.


Subject(s)
Adipose Tissue/cytology , Diabetes Mellitus, Experimental/drug therapy , Erectile Dysfunction/therapy , Hypoglycemic Agents/therapeutic use , Insulin, Isophane/therapeutic use , Penis/metabolism , Stem Cell Transplantation , Animals , Apoptosis/drug effects , Chemokine CXCL5/metabolism , Combined Modality Therapy , Diabetes Mellitus, Experimental/complications , Erectile Dysfunction/etiology , Erectile Dysfunction/physiopathology , Glycation End Products, Advanced/metabolism , Hypoglycemic Agents/administration & dosage , Inflammation/drug therapy , Inflammation/metabolism , Insulin, Isophane/administration & dosage , Male , Nitric Oxide Synthase Type I/metabolism , Penis/innervation , Peripheral Nerves/enzymology , Rats , Rats, Sprague-Dawley , Receptor for Advanced Glycation End Products/metabolism , Stem Cells/metabolism , Tissue Inhibitor of Metalloproteinase-1/metabolism , Vascular Endothelial Growth Factor A/metabolism
11.
Chin J Integr Med ; 22(10): 759-67, 2016 Oct.
Article in English | MEDLINE | ID: mdl-25159861

ABSTRACT

OBJECTIVE: To study the ability of aqueous extract of Hericium erinaceus mushroom in the treatment of nerve injury following peroneal nerve crush in Sprague-Dawley rats. METHODS: Aqueous extract of Hericium erinaceus was given by daily oral administration following peroneal nerve crush injury in Sprague-Dawley rats. The expression of protein kinase B (Akt) and mitogen-activated protein kinase (MAPK) signaling pathways; and c-Jun and c-Fos genes were studied in dorsal root ganglia (DRG) whereas the activity of protein synthesis was assessed in peroneal nerves by immunohistochemical method. RESULTS: Peripheral nerve injury leads to changes at the axonal site of injury and remotely located DRG containing cell bodies of sensory afferent neurons. Immunofluorescence studies showed that DRG neurons ipsilateral to the crush injury in rats of treated groups expressed higher immunoreactivities for Akt, MAPK, c-Jun and c-Fos as compared with negative control group (P <0.05). The intensity of nuclear ribonucleoprotein in the distal segments of crushed nerves of treated groups was significantly higher than in the negative control group (P <0.05). CONCLUSION: H. erinaceus is capable of promoting peripheral nerve regeneration after injury. Potential signaling pathways include Akt, MAPK, c-Jun, and c-Fos, and protein synthesis have been shown to be involved in its action.


Subject(s)
Agaricales/chemistry , Nerve Regeneration/physiology , Peripheral Nerves/physiology , Animals , Axons/pathology , Female , Ganglia, Spinal/metabolism , Glucans/analysis , MAP Kinase Signaling System , Nerve Crush , Peripheral Nerves/enzymology , Peroneal Nerve/physiology , Protein Biosynthesis , Proto-Oncogene Proteins c-akt/metabolism , Proto-Oncogene Proteins c-fos/genetics , Proto-Oncogene Proteins c-fos/metabolism , Proto-Oncogene Proteins c-jun/genetics , Proto-Oncogene Proteins c-jun/metabolism , Rats, Sprague-Dawley
12.
Toxicon ; 107(Pt A): 32-6, 2015 Dec 01.
Article in English | MEDLINE | ID: mdl-26130523

ABSTRACT

Botulinum neurotoxins (BoNTs) are Janus toxins, as they are at the same time the most deadly substances known and one of the safest drugs used in human therapy. They specifically block neurotransmission at peripheral nerves through the proteolysis of SNARE proteins, i.e. the essential proteins which are the core of the neuroexocytosis machinery. Even if BoNTs are traditionally known as seven main serotypes, their actual number is much higher as each serotype exists in many different subtypes, with individual biological properties and little antigenic relations. Since BoNTs can be used as biological weapons, and the only currently available therapy is based on immunological approaches, the existence of so many different subtypes is a major safety problem. Nevertheless, all BoNT isoforms are structurally similar and intoxicate peripheral nerve endings via a conserved mechanism. They consist of two chains linked by a unique disulphide bond which must be reduced to enable their toxicity. We found that thioredoxin 1 and its reductase compose the cell redox system responsible for this reduction, and its inhibition via specific chemicals significantly reduces BoNTs activity, in vitro as well as in vivo. Such molecules can be considered as lead compounds for the development of pan-inhibitors.


Subject(s)
Botulinum Toxins/metabolism , Synaptic Vesicles/metabolism , Thioredoxin-Disulfide Reductase/metabolism , Botulinum Antitoxin/metabolism , Humans , Oxidation-Reduction , Peripheral Nerves/enzymology , Peripheral Nerves/metabolism , Protein Isoforms/metabolism , Synaptic Vesicles/enzymology , Thioredoxin-Disulfide Reductase/antagonists & inhibitors
13.
Biomed Res Int ; 2014: 658753, 2014.
Article in English | MEDLINE | ID: mdl-24967390

ABSTRACT

Brachial plexus injury often involves traumatic root avulsion resulting in permanent paralysis of the innervated muscles. The lack of sufficient regeneration from spinal motoneurons to the peripheral nerve (PN) is considered to be one of the major causes of the unsatisfactory outcome of various surgical interventions for repair of the devastating injury. The present study was undertaken to investigate potential inhibitory signals which influence axonal regeneration after root avulsion injury. The results of the study showed that root avulsion triggered GSK-3ß activation in the injured motoneurons and remaining axons in the ventral funiculus. Systemic application of a clinical dose of lithium suppressed activated GSK-3ß in the lesioned spinal cord to the normal level and induced extensive axonal regeneration into replanted ventral roots. Our study suggests that GSK-3ß activity is involved in negative regulation for axonal elongation and regeneration and lithium, the specific GSK-3ß inhibitor, enhances motoneuron regeneration from CNS to PNS.


Subject(s)
Axons/enzymology , Enzyme Inhibitors/pharmacology , Glycogen Synthase Kinase 3/antagonists & inhibitors , Lithium/pharmacology , Motor Neurons/enzymology , Nerve Regeneration/drug effects , Peripheral Nerve Injuries , Peripheral Nerves/enzymology , Animals , Axons/pathology , Enzyme Activation , Female , Glycogen Synthase Kinase 3/metabolism , Glycogen Synthase Kinase 3 beta , Motor Neurons/pathology , Peripheral Nerve Injuries/drug therapy , Peripheral Nerve Injuries/enzymology , Peripheral Nerve Injuries/pathology , Rats , Rats, Sprague-Dawley , Spinal Nerve Roots/enzymology , Spinal Nerve Roots/injuries
14.
Neuropharmacology ; 80: 115-32, 2014 May.
Article in English | MEDLINE | ID: mdl-24452011

ABSTRACT

Epigenetic modifications in response to traumatic experience and stress are emerging as important factors in the long-term biological trajectories leading to stress-related psychiatric disorders, reflecting both environmental influences as well as individual genetic predisposition. In particular, recent evidence on DNA methylation changes within distinct genes and pathways but also on a genome-wide level provides new insights into the pathophysiology of stress related psychiatric disorders. This review summarizes current findings and concepts on DNA methylation changes in stress-related disorders with a focus on major depressive disorder and posttraumatic stress disorder (PTSD). We highlight studies of DNA methylation in animals and humans pertinent to these disorders, both focusing on candidate loci as well as genome-wide studies. We describe molecular mechanisms of how exposure to stress can induce long lasting changes in DNA methylation and how these may relate to the pathophysiology of depression and PTSD. We discuss data suggesting that DNA methylation, even in peripheral tissues, appears to be an informative reflection of environmental exposures on the genome and may have potential as a biomarker for the early prevention of stress-related disorders.


Subject(s)
Brain/metabolism , DNA Methylation , Depressive Disorder, Major/metabolism , Epigenesis, Genetic , Gene-Environment Interaction , Neurons/metabolism , Stress Disorders, Post-Traumatic/metabolism , Animals , Brain/enzymology , Depressive Disorder, Major/etiology , Gene Expression Regulation , Humans , Hypothalamo-Hypophyseal System/enzymology , Hypothalamo-Hypophyseal System/metabolism , Nerve Tissue Proteins/genetics , Nerve Tissue Proteins/metabolism , Neurons/enzymology , Peripheral Nerves/enzymology , Peripheral Nerves/metabolism , Pituitary-Adrenal System/enzymology , Pituitary-Adrenal System/innervation , Pituitary-Adrenal System/metabolism , Stress Disorders, Post-Traumatic/enzymology , Stress, Physiological , Stress, Psychological/psychology
15.
J Mol Histol ; 45(2): 121-8, 2014 Apr.
Article in English | MEDLINE | ID: mdl-23990368

ABSTRACT

Charcot-Marie-Tooth disease type 2D is a hereditary axonal and glycyl-tRNA synthetase (GARS)-associated neuropathy that is caused by a mutation in GARS. Here, we report a novel GARS-associated mouse neuropathy model using an adenoviral vector system that contains a neuronal-specific promoter. In this model, we found that wild-type GARS is distributed to peripheral axons, dorsal root ganglion (DRG) cell bodies, central axon terminals, and motor neuron cell bodies. In contrast, GARS containing a G240R mutation was localized in DRG and motor neuron cell bodies, but not axonal regions, in vivo. Thus, our data suggest that the disease-causing G240R mutation may result in a distribution defect of GARS in peripheral nerves in vivo. Furthermore, a distributional defect may be associated with axonal degradation in GARS-associated neuropathies.


Subject(s)
Adenoviridae/genetics , Charcot-Marie-Tooth Disease/enzymology , Animals , Axons/enzymology , Charcot-Marie-Tooth Disease/genetics , Charcot-Marie-Tooth Disease/pathology , Disease Models, Animal , Ganglia, Spinal/enzymology , Ganglia, Spinal/pathology , Genetic Vectors , Glycine-tRNA Ligase/genetics , Glycine-tRNA Ligase/metabolism , Male , Mice , Mice, Inbred C57BL , Mice, Transgenic , Motor Neurons/enzymology , Mutation, Missense , Nerve Fibers, Myelinated/enzymology , Organ Specificity , Peripheral Nerves/enzymology , Peripheral Nerves/pathology
16.
PLoS One ; 8(11): e79355, 2013.
Article in English | MEDLINE | ID: mdl-24223930

ABSTRACT

The endocannabinoid system modulates numerous physiological processes including nociception and reproduction. Anandamide (AEA) is an endocannabinoid that is inactivated by cellular uptake followed by intracellular hydrolysis by fatty acid amide hydrolase (FAAH). Recently, FAAH-like anandamide transporter (FLAT), a truncated and catalytically-inactive variant of FAAH, was proposed to function as an intracellular AEA carrier and mediate its delivery to FAAH for hydrolysis. Pharmacological inhibition of FLAT potentiated AEA signaling and produced antinociceptive effects. Given that endocannabinoids produce analgesia through central and peripheral mechanisms, the goal of the current work was to examine the expression of FLAT in the central and peripheral nervous systems. In contrast to the original report characterizing FLAT, expression of FLAT was not observed in any of the tissues examined. To investigate the role of FLAT as a putative AEA binding protein, FLAT was generated from FAAH using polymerase chain reaction and further analyzed. Despite its low cellular expression, FLAT displayed residual catalytic activity that was sensitive to FAAH inhibitors and abolished following mutation of its catalytic serine. Overexpression of FLAT potentiated AEA cellular uptake and this appeared to be dependent upon its catalytic activity. Immunofluorescence revealed that FLAT localizes primarily to intracellular membranes and does not contact the plasma membrane, suggesting that its capability to potentiate AEA uptake may stem from its enzymatic rather than transport activity. Collectively, our data demonstrate that FLAT does not serve as a global intracellular AEA carrier, although a role in mediating localized AEA inactivation in mammalian tissues cannot be ruled out.


Subject(s)
Amidohydrolases/metabolism , Arachidonic Acids/metabolism , Endocannabinoids/metabolism , Membrane Transport Proteins/metabolism , Polyunsaturated Alkamides/metabolism , Amidohydrolases/genetics , Animals , Gene Expression Regulation, Enzymologic , HeLa Cells , Humans , Membrane Transport Proteins/genetics , Mice , Peripheral Nerves/enzymology , Protein Transport
17.
Curr Opin Genet Dev ; 23(3): 302-9, 2013 Jun.
Article in English | MEDLINE | ID: mdl-23465884

ABSTRACT

Aminoacyl-tRNA synthetases (ARSs) are ubiquitously expressed, essential enzymes responsible for the first step of protein translation--attaching amino acids to cognate tRNA molecules. Interestingly, ARS gene mutations have been implicated in tissue-specific human diseases, including inherited peripheral neuropathies. To date, five loci encoding an ARS have been implicated in peripheral neuropathy, and alleles at each locus show loss-of-function characteristics. The majority of the phenotypes are autosomal dominant, and each of the implicated enzymes acts as an oligomer, indicating that a dominant-negative effect should be considered. On the basis of current data, impaired tRNA charging is likely to be a central component of ARS-related neuropathy. Future efforts should focus on testing this notion and developing strategies for restoring ARS function in the peripheral nerve.


Subject(s)
Amino Acyl-tRNA Synthetases/genetics , Charcot-Marie-Tooth Disease/genetics , Peripheral Nervous System Diseases/genetics , Protein Biosynthesis/genetics , Charcot-Marie-Tooth Disease/enzymology , Charcot-Marie-Tooth Disease/etiology , Humans , Mutation , Peripheral Nerves/enzymology , Peripheral Nerves/pathology , Peripheral Nervous System Diseases/enzymology , Peripheral Nervous System Diseases/etiology , Phenotype
18.
Cell Tissue Res ; 351(3): 497-510, 2013 Mar.
Article in English | MEDLINE | ID: mdl-23250574

ABSTRACT

Conventional choline acetyltransferase immunohistochemistry has been used widely for visualizing central cholinergic neurons and fibers but not often for labeling peripheral structures, probably because of their poor staining. The recent identification of the peripheral type of choline acetyltransferase (pChAT) has enabled the clear immunohistochemical detection of many known peripheral cholinergic elements. Here, we report the presence of pChAT-immunoreactive nerve fibers in rat skin. Intensely stained nerve fibers were distributed in association with eccrine sweat glands, blood vessels, hair follicles and portions just beneath the epidermis. These results suggest that pChAT-positive nerves participate in the sympathetic cholinergic innervation of eccrine sweat glands. Moreover, pChAT also appears to play a role in cutaneous sensory nerve endings. These findings are supported by the presence of many pChAT-positive neuronal cells in the sympathetic ganglion and dorsal root ganglion. Thus, pChAT immunohistochemistry should provide a novel and unique tool for studying cholinergic nerves in the skin.


Subject(s)
Choline O-Acetyltransferase/metabolism , Peripheral Nerves/enzymology , Skin/enzymology , Skin/innervation , Animals , Eccrine Glands/enzymology , Eccrine Glands/innervation , Ganglia, Spinal/cytology , Ganglia, Spinal/enzymology , Ganglia, Spinal/surgery , Ganglia, Sympathetic/cytology , Ganglia, Sympathetic/enzymology , Ganglia, Sympathetic/surgery , Ganglionectomy , Immunohistochemistry , Nerve Fibers/metabolism , Neuronal Tract-Tracers , Peripheral Nerves/cytology , Rats , Rats, Wistar , Substance P/metabolism , Tyrosine 3-Monooxygenase/metabolism , Vesicular Acetylcholine Transport Proteins/metabolism
19.
Brain Res ; 1475: 19-30, 2012 Sep 26.
Article in English | MEDLINE | ID: mdl-22898152

ABSTRACT

The Na(+)/H(+) exchanger (NHE) is involved in the regulation of intracellular pH and volume by mediating the electroneutral transport of H(+) against an influx of Na(+) ions. Since NHE1 regulates pH in neurons and astrocytes and it is expressed in nociceptive nerve fibers, it is likely that NHE may modulate neuronal excitability and pain transmission. The purpose of this study was to assess the participation of peripheral and spinal NHE in the secondary allodynia/hyperalgesia induced by formalin. In addition, we determined whether formalin injection modifies the expression of NHE1 in lumbar dorsal root ganglia (DRG) and dorsal spinal cord. Subcutaneous injection of 0.5% formalin into the dorsal surface of the hind paw produced acute nociceptive behaviors (flinching and licking/lifting) followed by long-lasting bilateral secondary mechanical allodynia/hyperalgesia. Peripheral and intrathecal pre-treatment (-10min) with selective NHE inhibitors 5-(N,N-dimethyl)amiloride hydrochloride (DMA, 0.3-30µM), 5-(N-ethyl-N-isopropyl)amiloride (EIPA, 0.3-30µM) and [1-(quinolin-5-yl)-5-cyclopropyl-1H-pyrazole-4-carbonyl] guanidine dihydrochloride (zoniporide, 0.03-3µM) significantly increased 0.5% formalin-induced bilateral long-lasting secondary allodynia/hyperalgesia. Contrariwise, local peripheral or intrathecal post-treatment (day 6 postinjection) with these NHE inhibitors did not affect formalin-induced nociceptive behaviors. Formalin injection reduced NHE1 expression in ipsilateral and contralateral spinal dorsal horns from day 1 to 12. In addition, formalin diminished NHE1 protein expression in DRG at day 12. These results suggest that NHE1 plays a role in pain processing at peripheral and spinal levels in formalin-induced long-lasting nociceptive behaviors. Additionally, these results suggest that proteins involved in pH regulation could be targets for the development of new analgesic drugs.


Subject(s)
Hyperalgesia/enzymology , Pain Measurement/methods , Peripheral Nerves/enzymology , Sodium-Hydrogen Exchangers/antagonists & inhibitors , Sodium-Hydrogen Exchangers/biosynthesis , Spinal Cord/enzymology , Amiloride/administration & dosage , Amiloride/analogs & derivatives , Animals , Female , Hyperalgesia/chemically induced , Injections, Spinal , Pain Measurement/drug effects , Peripheral Nerves/drug effects , Physical Stimulation/adverse effects , Rats , Rats, Wistar , Sodium-Hydrogen Exchanger 1 , Sodium-Hydrogen Exchangers/physiology , Spinal Cord/drug effects
20.
Arch Toxicol ; 86(5): 767-77, 2012 May.
Article in English | MEDLINE | ID: mdl-22354540

ABSTRACT

The kinetic analysis of esterase inhibition by acylating compounds (organophosphorus carbamates and sulfonyl fluorides) is sometimes unable to yield consistent results by fitting simple inhibition kinetic models to experimental data of complex systems. In this work, kinetic data were obtained for phenylmethylsulfonyl fluoride (PMSF) tested at different concentrations incubated for up to 3 h with soluble fraction of chicken peripheral nerve. PMSF is a protease and esterase inhibitor causing protection or potentiation of the organophosphorus-induced delayed neuropathy and is unstable in water solution. The target of the promotion effect was proposed to be a soluble esterase not yet identified. A kinetic model equation was deduced assuming a multienzymatic system with three different molecular phenomena occurring simultaneously: (1) inhibition, (2) spontaneous chemical hydrolysis of the inhibitor and (3) ongoing inhibition (inhibition during the substrate reaction). A three-dimensional fit of the model was applied for analyzing the experimental data. The best-fitting model is compatible with a resistant component (16.5-18%) and two sensitive enzymatic entities (both 41%). The corresponding second-order rate constants of inhibition (ki = 12.04 × 10⁻² and 0.54 × 10⁻² µM⁻¹ min⁻¹, respectively) and the chemical hydrolysis constant of PMSF (kh = 0.0919 min⁻¹) were simultaneously estimated. These parameters were similar to those deduced in fixed-time inhibition experiments. The consistency of results in both experiments was considered an internal validation of the methodology. The results were also consistent with a significant ongoing inhibition. The proportion of enzymatic components showed in this work is similar to those previously observed in inhibition experiments with mipafox, S9B and paraoxon, demonstrating that this kinetic approach gives consistent results in complex enzymatic systems.


Subject(s)
Esterases/antagonists & inhibitors , Peripheral Nerves/drug effects , Peripheral Nerves/enzymology , Phenylmethylsulfonyl Fluoride/pharmacokinetics , Animals , Chickens , Enzyme Inhibitors/pharmacokinetics , Esterases/metabolism , Hydrolysis , In Vitro Techniques , Models, Theoretical , Neurotoxicity Syndromes/etiology , Organoplatinum Compounds/toxicity
SELECTION OF CITATIONS
SEARCH DETAIL
...